How many insider trades does FilingIQ track for SGMT?

FilingIQ tracks 69 Form 4 insider transactions for SGMT (Sagimet Biosciences Inc.), covering filings from Jul 18, 2023 onwards. 9 of those were filed in the last 90 days.

Are SGMT insiders net buyers or net sellers?

Across the full Form 4 history for SGMT, 5 transactions (7%) were open-market purchases and 13 (19%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SGMT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SGMT in?

Sagimet Biosciences Inc. (SGMT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $165.70M.

SGMT insider trading

Healthcare

Sagimet Biosciences Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

7% / 19%

Market cap

$165.70M

About Sagimet Biosciences Inc.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs, such as various solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Company website: www.sagimet.com

SGMT insider activity at a glance

FilingIQ has scored 69 insider transactions for SGMT since Jul 18, 2023. The most recent filing in our index is dated Apr 20, 2026.

Across the full history, 5 open-market purchases and 13 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SGMT insider trades is 57.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SGMT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for SGMT?: FilingIQ tracks 69 Form 4 insider transactions for SGMT (Sagimet Biosciences Inc.), covering filings from Jul 18, 2023 onwards. 9 of those were filed in the last 90 days.
Are SGMT insiders net buyers or net sellers?: Across the full Form 4 history for SGMT, 5 transactions (7%) were open-market purchases and 13 (19%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SGMT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SGMT in?: Sagimet Biosciences Inc. (SGMT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $165.70M.

Methodology & sources

Every SGMT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.